China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced a licensing agreement with South Korea’s C&V Tech, a glaucoma device firm. The agreement grants Zhaoke exclusive rights for registration, import, promotion, distribution, marketing, and sales of C&V Tech’s TONO-i tonometer in Greater China. No financial details were disclosed.
TONO-i Tonometer Profile
The innovative TONO-i tonometer is designed to be touch-free, portable, self-measuring, and affordable. Unlike traditional contact tonometers, it can be safely used without pain or infection risk and does not require anesthesia. This device is particularly helpful for accurately monitoring patients’ intraocular pressure, providing immediate and continuous disease feedback, and improving patient compliance with glaucoma drug treatment.
Future Development and Impact
This licensing agreement underscores Zhaoke Ophthalmology’s commitment to advancing glaucoma management in Greater China. By introducing the TONO-i tonometer, Zhaoke aims to enhance patient outcomes through improved monitoring and treatment adherence, ultimately contributing to better management of glaucoma.-Fineline Info & Tech
